CXCL9 and juvenile idiopathic arthritis: Introduction: To date, several studies have validated the use of key biomarkers such as IL-18, CXCL9 and S100 proteins in diagnosis and monitoring of treatment response of systemic juvenile idiopathic arthritis (sJIA).